Carregant...
Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
IMPORTANCE: List prices set by manufacturers for brand-name prescription drugs in the US have been increasing faster than inflation, although confidential manufacturer rebates offset some of these increases. Most commercially insured patients pay at least some out-of-pocket costs for prescription dr...
Guardat en:
| Publicat a: | JAMA Netw Open |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Medical Association
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8097497/ https://ncbi.nlm.nih.gov/pubmed/33944925 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2021.8816 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|